PolyPid Ltd. (PYPD) Financials

PYPD Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 15.4 million 17.5 million
2023-09-30 20.9 million 17.4 million
2023-06-30 26.3 million 17.9 million
2023-03-31 31.7 million 20.3 million

PYPD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 ? ?
2023-09-30 ? ?
2023-06-30 ? ?
2023-03-31 ? ?

PYPD Net Income

No data available :(

PYPD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 5.6 million - 1.4 million
2023-09-30 10.2 million - 1.3 million
2023-06-30 15.1 million - 1.6 million
2023-03-31 13.4 million - 1.9 million

PYPD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 1.7 million
2023-09-30 1.7 million
2023-06-30 1.5 million
2023-03-31 716555

PYPD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 4.6 million 1.2 million 193000
2023-09-30 - 3.8 million 1.2 million 261000
2023-06-30 - 4.0 million 1.7 million 166000
2023-03-31 - 3.8 million 1.6 million 385000

PYPD Cost of Revenue

No data available :(

PYPD

Price: $4.94

52 week price:
3.57
14.10

Earnings Per Share: -16.99 USD

P/E Ratio: -0.29

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 407700

Market Capitalization: 22.1 million

Links: